M&A Deal Summary

Merck Acquires Millipore

On February 27, 2010, Merck acquired test/measurement equipment company Millipore for 7.2B USD

Acquisition Highlights
  • This is Merck’s 1st transaction in the Test/Measurement Equipment sector.
  • This is Merck’s 2nd largest (disclosed) transaction.
  • This is Merck’s 2nd transaction in the United States.
  • This is Merck’s 1st transaction in Massachusetts.

M&A Deal Summary

Date 2010-02-27
Target Millipore
Sector Test/Measurement Equipment
Buyer(s) Merck
Deal Type Add-on Acquisition
Deal Value 7.2B USD
Advisor(s) Goldman Sachs (Financial)
Cravath, Swaine & Moore (Legal)

Target

Millipore

Billerica, Massachusetts, United States
Millipore Corp. is a Life Science company providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Merck

Darmstadt, Germany

Category Company
Founded 1668
Sector Diversified
Employees64,011
Revenue 21.2B EUR (2024)
DESCRIPTION

Merck is a science and technology company in healthcare, life science, and performance materials. It develops technologies that improve and enhance life, from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Merck was founded in 1668 and is based in Darmstadt, Germany.


DEAL STATS #
Overall 4 of 26
Sector: Test/Measurement Equipment M&A 1 of 2
Type: Add-on Acquisition M&A Deals 3 of 21
State: Massachusetts M&A 1 of 1
Country: United States M&A 2 of 12
Year: 2010 M&A 1 of 1
Size (of disclosed) 2 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-09-09 Suzhou Taizhu Technology Development Co.

Taicang, China

Suzhou Taizhu Technology Development Co., Ltd. is a provider of effect pigments for printing, plastics, coating, and cosmetics industries.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-28 Thermamex

London, United Kingdom

Theramex is a global specialty pharmaceutical company dedicated to women and their health. The Company markets a broad range of branded and branded generic products across 50 countries around the world. The portfolio, which is dedicated to women's health, focuses on contraception, fertility, menopause and osteoporosis and includes key brands such as Ovaleap®, Zoely®, Seasonique®, Actonel®, Estreva® and Lutenyl®. Thermamex is based in London, United Kingdom.

Sell €265M